Categories: AlphaGraphs

Tesla starts taking in orders for new cheap Model 3 variant in China

Elon Musk has his eyes on the Chinese market. His latest move for a cheaper Tesla car for the Asian country is a testament to it.

On Friday, Feb. 1, Tesla announced that the electric car company has started taking orders for its cheaper Model 3 variant.

This rear-wheel-drive variant is priced at 433,000 yuan (about $64,300), considerably lower than its all-wheel-drive counterpart with a price tag of 499,000 yuan.

According to Tesla, deliveries of the new model will commence in March.

CHINA-BUILT TESLA, COMING SOON

Due to the onset of heavy retaliatory tariffs by Beijing on US autos, Tesla in October declared its negative impact on sales. Following this, the company has hinted at a Shanghai plant to build the cars in the country for China customers.

 

ENCOURAGING MOVE POST RESULTS

Earlier this week, Tesla announced that it delivered a record number of vehicles in the final months of 2018, and reported stronger than expected revenues for the fourth quarter. However, earnings fell short of expectations sending the stock falling.

This latest move to more China-based sales could help Tesla get back on its feet.

Tesla now expects Model 3 volumes to grow sharply in FY 2019, helped by high production volumes at the Fremont factory. The company looks to start full-fledged production of Model 3 vehicles at its Gigafactory in Shanghai by year-end.

 

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Recent Posts

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

5 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

7 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

31 minutes ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

46 minutes ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

53 minutes ago

Harley-Davidson Q4 2025 Results Reflect Margin Pressure

Overview Harley-Davidson, Inc. reported consolidated fourth-quarter 2025 results that point to continued pressure on profitability…

1 hour ago